Updated Jul 16, 2026
KIM PETER S has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $732K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-05-13 | TRDA | Entrada Therapeutics, Inc. | P — Open-market purchase | 25.0K | $14.59 | $365K |
| 2024-05-13 | TRDA | Entrada Therapeutics, Inc. | P — Open-market purchase | 25.0K | $14.68 | $367K |
KIM PETER S is a corporate insider — currently tracked as Director of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($732K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live KIM PETER S profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.